Pyridam Farma’s loss worsened to IDR 214.2 billion in 9M 2024
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
PYFA subsidiary secures US$ 15 million loan from HSBC
19 Jul 2024 09:51
One of the subsidiaries of PT Pyridam Farma Tbk (PYFA), namely Pyfa Health Singapore Pte. Ltd. (Pyfa Singapore), has obtained a credit facility worth US$ 15 million or around IDR 242.6 billion.
Pyridam Farma eyes IDR 400 billion through bonds’ issuance
26 Jan 2024 09:26
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company under Rejuve Global Investment, will issue its Shelf-Registration Bonds I of PYFA Phase III Year 2024, with a total principal of IDR 400 billion.
PYFA granted approval from shareholders to offer 16 billion shares in rights issue
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.
PYFA to acquire Australian pharmaceutical company, Probiotec
22 Dec 2023 09:36
PT Pyridam Farma Tbk (PYFA) has signed a Scheme Implementation Deed (SID) regarding the plan of one of its subsidiaries to take over shares of Probiotec, an Australia-based pharmaceutical company.
Pyridam Farma will carry out rights issue of 16 billion shares
28 Nov 2023 21:01
PT Pyridam Farma Tbk (PYFA) will issue 16 billion new shares by providing Pre-emptive Rights (HMETD) or rights issue.
Once postponed, PYFA to re-offer bonds of IDR 400 billion
15 Sep 2023 09:57
PT Pyridam Farma Tbk (PYFA) once again offers Shelf-Registration Bonds I of PYFA Phase II Year 2023 with a total principal of IDR 400 billion.
Pyridam Farma aims IDR 400 billion fresh funds through bond issuance
29 Aug 2023 20:40
PT Pyridam Farma Tbk (PYFA) will issue Shelf Registration Bonds I Phase II Year 2023, with a principal amount of IDR 400 billion.
Pyridam Farma disbursed IDR 5 billion loan to Holi Pharma
23 Jun 2023 10:31
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company that has been operating commercially since 1977, has provided a loan facility of IDR 5 billion to one of its subsidiaries, namely PT Holi Pharma (HP).
